Advertisement
Advertisement

PHGE

PHGE logo

BiomX Inc

0.6274
USD
-0.0257
-3.94%
Dec 18, 15:18 UTC -5
Closed
...

BiomX Inc Profile

About

BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel.

Info & Links

CEO

Jonathan Solomon

Headquarters

22 EINSTEIN ST., 4TH FLOOR
NESS ZIONA, L3 7414003, ISRAEL

Industry

Biotechnology

Sector

Health Technology

Website

www.biomx.com

Auditor

Kesselman & Kesselman

Share holders

75

Employees

71

BiomX Inc Statistics

Valuation Measures

Market Capitalization2

11.41M

Enterprise Value

-13.24M

Enterprise Value/EBITDA(ttm)

0.43

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.59

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-2539.72%

Return on Invested Capital(ttm)

-98.73%

Return on Assets(ttm)

-84.14%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-31.10M

Net Income Available to Common(ttm)

-8.71M

Diluted EPS(ttm)

-3.21

Share Statistics

Beta (5Y Monthly)

1.31

52-Week Change

-76.78%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

18.18M

Dividend Yield

0.00%

Float4

17.63M

% Held by Insiders

3.01%

% Held by Institutions

40.57%

Balance Sheet

Total Cash(mrq)

24.65M

Total Cash Per Share(mrq)

1.36

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.17%

Quick Ratio(mrq)

3.17%

Book Value Per Share(mrq)

2.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.87

Free Cash Flow(ytd)

-30.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement